Browse by Research Project Code

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0

Kurowska-Stolarska, M. et al. (2017) The role of microRNA-155/LXR pathway in experimental and Idiopathic Pulmonary Fibrosis. Journal of Allergy and Clinical Immunology, 139(6), pp. 1946-1956. (doi: 10.1016/j.jaci.2016.09.021) (PMID:27746237) (PMCID:PMC5457127)

Rossi, S. H. et al. (2013) Impaired renal function impacts negatively on vascular stiffness in patients with coronary artery disease. BMC Nephrology, 14(173), (doi: 10.1186/1471-2369-14-173)

Weir, R. A.P. et al. (2013) Galectin-3 and cardiac function in survivors of acute myocardial infarction. Circulation: Heart Failure, 6(3), pp. 492-498. (doi: 10.1161/CIRCHEARTFAILURE.112.000146) (PMID:23505301)

Miller, A. M. , Gilchrist, D. S. , Nijjar, J. , Araldi, E. , Ramirez, C. M. , Lavery, C. A. , Fernández-Hernando, C. , McInnes, I. B. and Kurowska-Stolarska, M. (2013) MiR-155 has a protective role in the development of non-alcoholic hepatosteatosis in mice. PLoS ONE, 8(8), e72324. (doi: 10.1371/journal.pone.0072324) (PMID:23991091) (PMCID:PMC3749101)

Caporali, A. et al. (2012) Soluble ST2 is regulated by p75 neurotrophin receptor and predicts mortality in diabetic patients with critical limb ischemia. Arteriosclerosis, Thrombosis, and Vascular Biology, 32(12), e149-e160. (doi: 10.1161/ATVBAHA.112.300497) (PMID:23065828) (PMCID:PMC3616363)

Miller, A. M. et al. (2012) Soluble ST2 associates with diabetes but not established cardiovascular risk factors: a new inflammatory pathway of relevance to diabetes? PLoS ONE, 7(10), e47830. (doi: 10.1371/journal.pone.0047830) (PMID:23112853) (PMCID:PMC3480428)

Weir, R. A.P. , Miller, A. M. , Petrie, C. J. , Clements, S. , Steedman, T. , Dargie, H. J. , Squire, I. B. , Ng, L. L. , McInnes, I. B. and McMurray, J. J.V. (2012) Interleukin-21 – a biomarker of importance in predicting myocardial function following acute infarction? Cytokine, 60(1), pp. 220-225. (doi: 10.1016/j.cyto.2012.06.002) (PMID:22748465)

Hueber, A. J. , Alves-Filho, J. C. , Asquith, D. L. , Michels, C. , Millar, N. L. , Reilly, J. H. , Graham, G. J. , Liew, F. Y. , Miller, A. M. and McInnes, I. B. (2011) IL-33 induces skin inflammation with mast cell and neutrophil activation. European Journal of Immunology, 41(8), pp. 2229-2237. (doi: 10.1002/eji.201041360) (PMID:21674479)

Miller, A. M. and Liew, F. Y. (2011) The IL-33/ST2 pathway — A new therapeutic target in cardiovascular disease. Pharmacology and Therapeutics, 131(2), pp. 179-186. (doi: 10.1016/j.pharmthera.2011.02.005)

Miller, A. M. (2011) Role of IL-33 in inflammation and disease. Journal of Inflammation, 8(1), p. 22. (doi: 10.1186/1476-9255-8-22)

Miller, A. and McInnes, I. (2011) Cytokines as therapeutic targets to reduce cardiovascular risk in chronic inflammation. Current Pharmaceutical Design, 17(1), pp. 1-8. (doi: 10.2174/138161211795049796) (PMID:21222645)

Miller, A. M. , Asquith, D. L. , Hueber, A. J. , Anderson, L. A. , Holmes, W. M. , McKenzie, A. N. , Xu, D. , Sattar, N. , McInnes, I. B. and Liew, F. Y. (2010) Interleukin-33 induces protective effects in adipose tissue inflammation during obesity in mice. Circulation Research, 107(5), pp. 650-658. (doi: 10.1161/CIRCRESAHA.110.218867) (PMID:20634488) (PMCID:PMC4254700)

Miller, A. M. , Xu, D. , Asquith, D. L. , Denby, L. , Li, Y. , Sattar, N. , Baker, A. H. , McInnes, I. B. and Liew, F. Y. (2008) IL-33 reduces the development of atherosclerosis. Journal of Experimental Medicine, 205(2), pp. 339-346. (doi: 10.1084/jem.20071868) (PMID:18268038) (PMCID:PMC2271006)

This list was generated on Tue Sep 29 15:59:23 2020 BST.